ASK REDCHAT ANYTHING ABOUT UNIQURE N.V.
uniQure N.V. (NASDAQ: QURE)
Listen to this Section
$28.90
+2.1350
(
+7.98% )
1.6M
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| HEMGENIX® (etranacogene dezaparvovec-drlb) (AMT-061)DetailsHemophilia, Rare diseases, Rare genetic disease |
Approved |
| AMT-191DetailsFabry disease, Genetic disorder |
Phase 1/2 |
| AMT-130DetailsHuntington's disease, Genetic disorder |
Phase 1/2 |
| AMT-260DetailsEpilepsy, Mesial temporal lobe epilepsy |
Phase 1/2 |
| AMT-162DetailsAmyotrophic lateral sclerosis |
Phase 1/2 |
Market Data
|
| Open |
$28.90 |
| Previous Close |
$26.76 |
| Volume |
1.6M |
| Market Cap |
$1.69B |
| Day Range |
$26.72 - $29.36 |
| 52 Week Range |
$8.73 - $71.50 |
| Shares Outstanding |
63.07M |
| Change % |
+7.98% |
| Net Change |
▲ 2.1350 |
| Insider Ownership |
-0.01% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2014 |
| Country | Netherlands |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-477,017.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-06-28 |
Sale |
-1447.00 |
Abi-Saab Walid |
| 2024-06-21 |
Sale |
-8080.00 |
Kaye Jack |
| 2024-06-21 |
Sale |
-8080.00 |
Springhorn Jeremy P. |
| 2024-06-21 |
Sale |
-8080.00 |
Jacques Rachelle Suzanne |
| 2024-06-21 |
Sale |
-8080.00 |
Meek David D. |
| 2024-06-21 |
Sale |
-8080.00 |
Gut Robert |
| 2024-06-21 |
Sale |
-8080.00 |
POST LEONARD E |
| 2024-06-21 |
Sale |
-8080.00 |
Balachandran Madhavan |
| 2024-06-20 |
Sale |
-2936.00 |
CALOZ PIERRE |
| 2024-06-20 |
Sale |
-1611.00 |
KLEMT CHRISTIAN |